BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27626608)

  • 1. Investigation into Iron Chelating and Antioxidant Potential of Melilotus officinalis in Iron Dextran Induced Iron Overloaded Sprague Dawley Rat Model.
    Sheikh NA; Desai TR; Tirgar PR
    Drug Res (Stuttg); 2016 Dec; 66(12):618-627. PubMed ID: 27626608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of iron chelating and antioxidant potential of Epilobium hirsutum for the management of iron overload disease.
    Sheikh NA; Desai TR; Tirgar PR
    Biomed Pharmacother; 2017 May; 89():1353-1361. PubMed ID: 28320102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Medicago Sativa and Allium Porrum on Iron Overload in Rats.
    Mirzaei A; Delaviz H; Mirzaei M; Tolooei M
    Glob J Health Sci; 2015 Apr; 7(7 Spec No):137-42. PubMed ID: 26153214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of iron overload-induced liver toxicity by a potent antioxidant and iron chelator, Emblica officinalis Gaertn.
    Sarkar R; Hazra B; Mandal N
    Toxicol Ind Health; 2015 Jul; 31(7):656-69. PubMed ID: 23524878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
    Ishizaka N; Saito K; Mori I; Matsuzaki G; Ohno M; Nagai R
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2282-8. PubMed ID: 16100038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    J Lab Clin Med; 2001 Aug; 138(2):130-8. PubMed ID: 11477380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
    Bergeron RJ; Wiegand J; Brittenham GM
    Blood; 1999 Jan; 93(1):370-5. PubMed ID: 9864183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats.
    Emara AM; El Kelany RS; Moustafa KA
    Hum Exp Toxicol; 2006 Jul; 25(7):375-85. PubMed ID: 16898166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload.
    Sripetchwandee J; Wongjaikam S; Krintratun W; Chattipakorn N; Chattipakorn SC
    Neuroscience; 2016 Sep; 332():191-202. PubMed ID: 27403880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regression of endometriosis with glycosylated flavonoids isolated from Melilotus officinalis (L.) Pall. in an endometriosis rat model.
    Ilhan M; Ali Z; Khan IA; Taştan H; Küpeli Akkol E
    Taiwan J Obstet Gynecol; 2020 Mar; 59(2):211-219. PubMed ID: 32127140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant and iron-chelating agents in cerebral vasospasm.
    Luo Z; Harada T; London S; Gajdusek C; Mayberg MR
    Neurosurgery; 1995 Dec; 37(6):1154-8; discussion 1158-9. PubMed ID: 8584156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objectives and mechanism of iron chelation therapy.
    Hershko C; Link G; Konijn AM; Cabantchik ZI
    Ann N Y Acad Sci; 2005; 1054():124-35. PubMed ID: 16339658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phenolics from Spondias pinnata bark in amelioration of iron overload induced hepatic damage in Swiss albino mice.
    Chaudhuri D; Ghate NB; Panja S; Mandal N
    BMC Pharmacol Toxicol; 2016 Jul; 17(1):34. PubMed ID: 27459849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iron chelating activity of Gundelia tournefortii in iron overloaded experimental rats.
    Mansi K; Tabaza Y; Aburjai T
    J Ethnopharmacol; 2020 Dec; 263():113114. PubMed ID: 32736049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute iron overload and oxidative stress in brain.
    Piloni NE; Fermandez V; Videla LA; Puntarulo S
    Toxicology; 2013 Dec; 314(1):174-82. PubMed ID: 24120471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBED: A potential alternative to deferoxamine for iron-chelating therapy.
    Bergeron RJ; Wiegand J; Brittenham GM
    Blood; 1998 Feb; 91(4):1446-52. PubMed ID: 9454776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload.
    Alta EC; Goswami D; Machini MT; Silvestre DM; Nomura CS; Espósito BP
    Biometals; 2014 Dec; 27(6):1351-60. PubMed ID: 25265871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Mangiferin in the Prevention of Experimentally Induced Iron Overload in an Animal Model.
    Estuningtyas A; Setiabudy R; Wahidiyat PA; Freisleben HJ
    Drug Res (Stuttg); 2019 Apr; 69(4):234-240. PubMed ID: 30189460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanillin serves as a potential substitute for chemical chelator desferal in iron-overloaded mice.
    Aalikhani M; Taheri E; Khalili M
    Eur J Pharmacol; 2023 Dec; 960():176153. PubMed ID: 38059446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide in iron-induced rat renal injury.
    Kadkhodaee M; Gol A
    Hum Exp Toxicol; 2004 Nov; 23(11):533-6. PubMed ID: 15625779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.